Latest Medicare Data Suggests No Heightened Death Risk For Paclitaxel-Coated Devices
Executive Summary
A large study of US Medicare patients treated with either drug-coated stents, balloons or other equivalent devices shows a similar morbidity rate in both groups, further contradicting a 2018 literature review that warned of higher death rates in patients treated with paclitaxel-coated devices.